BCKDK and hepatocellular carcinoma: Mechanistically, Src kinase-mediated phosphorylation and activation of BCKDK in HCC cells promoted cell migration and activated the ERK pathway, linking suppressed BCAA catabolism to pro-metastatic signaling [64].